A Livent Corp sign hangs on the New York Stock Exchange (NYSE) in Manhattan as lithium producer Livent Corp holds its IPO in New York, U.S., October 11, 2018. REUTERS/Brendan McDermid/file photo Acquire Licensing Rights
SYDNEY, Dec 19 (Reuters) – Australia’s Allkem (AKE.AX) investors have approved Livent Corp (LTHM.N) $10.6 bln merger on proxy votes at a shareholder meeting in Perth on Tuesday.
Reporting by Scott Murdoch in Sydney; Editing by Jacqueline Wong
-Advertisement-
